From immunotherapy to mRNA vaccines—the latest science on melanoma treatment explained
More than 16,000 Australians will be diagnosed with melanoma each year. Most of these will be caught early, and can be cured by surgery.
Jun 5, 2024
0
32
Amino Acids, Peptides, and Proteins: News and Research on Ipilimumab
MeSH tree: D12.776.124.486.485.114.224.060.798
Lack of insurance keeps many Americans from best cancer meds
A cutting-edge class of drugs is saving and extending the lives of cancer patients.
Jun 3, 2024
0
21
Immunotherapy combination may benefit patients with transplanted kidneys and advanced skin cancers
People who have had a kidney transplant are at high risk for developing skin cancers. New research directed by investigators from the Johns Hopkins Kimmel Cancer Center is exploring the best combination of treatments to target ...
Feb 28, 2024
0
36
Clinical trial shows immunotherapy before surgery leads to promising long-term survival in sarcoma patients
Patients with soft-tissue sarcoma treated with neoadjuvant, or pre-surgical, immunotherapy had very little residual tumor at the time of surgery and promising long-term survival, according to Phase II trial results published ...
Feb 13, 2024
0
49
Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer
A team led by the National Cancer Centre Singapore (NCCS) with members from Singapore General Hospital, A*STAR's Institute of Molecular and Cell Biology (IMCB) and Genome Institute of Singapore (GIS), National University ...
Jun 7, 2023
0
80
Clinical trial: Three-drug combination slows progression of advanced kidney cancer
A targeted kinase inhibitor added to a two-drug immunotherapy combination slowed the progression of advanced kidney cancer in previously untreated patients, according to research led by an oncologist from Dana-Farber Cancer ...
May 10, 2023
0
57
Clinical trial shows tumor-starving drug improves survival of mesothelioma
Peter Szlosarek, Professor of Medical Oncology at Queen Mary's Barts Cancer Institute, presented his team's results from the ATOMIC-Meso clinical trial in partnership with Polaris Pharmaceuticals, Inc., at the American Association ...
Apr 18, 2023
0
77
Dual immunotherapy plus chemotherapy before surgery improves patient outcomes in operable lung cancer
In a Phase II trial led by researchers from The University of Texas MD Anderson Cancer Center, adding ipilimumab to a neoadjuvant, or pre-surgical, combination of nivolumab plus platinum-based chemotherapy, resulted in a ...
Mar 16, 2023
0
74
Healthy gut bacteria can help fight cancer in other parts of the body, researchers find
Researchers at UT Southwestern Medical Center have discovered how healthy bacteria can escape the intestine, travel to lymph nodes and cancerous tumors elsewhere in the body, and boost the effectiveness of certain immunotherapy ...
Mar 9, 2023
0
138
Are the benefits of new cancer drugs worth the cost?
An international research group including scientists from Italy, the United States, Ireland, and Israel have published a three-year analysis of the Mesothelioma (Me) drug trial, Check-Mate 743 (CM-743). The trial studied ...
Dec 21, 2022
0
44
